‘Delighted with growth’: Aussie supplement firms increase market size despite pandemic trials and tribulations – new data Australia’s supplements industry has continued to grow amid the pandemic despite a dip in export revenue, with firms finding success by pivoting to immunity products and finding inroads into several new markets, including Iran, Israel and Brazil.
This is according to new data published by Complementary Medicines Australia (CMA) in its Industry Audit 2021 report.
The sector valued at AUD$5.69bn (US$4.2bn) last year, up 1.5 per cent from the year before.
Similar to last year, the biggest category was vitamin and dietary supplements valued at AUD$3.1bn (US$2.3bn), followed by sports supplements at AUD$1.4bn (US$1.05bn), herbal products at AUD$750m (US$563m), and weight loss products at AUD$440m (US$330m).